239 related articles for article (PubMed ID: 26583648)
1. Optimizing Care and Compliance for the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
Benjamin Chase A; Markel K; Tawa MC
Clin J Oncol Nurs; 2015 Dec; 19(6):E131-9. PubMed ID: 26583648
[TBL] [Abstract][Full Text] [Related]
2. Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma.
Talpur R; Venkatarajan S; Duvic M
Expert Rev Clin Pharmacol; 2014 Sep; 7(5):591-7. PubMed ID: 25068889
[TBL] [Abstract][Full Text] [Related]
3. Topical chemotherapy in cutaneous T-cell lymphoma: positive results of a randomized, controlled, multicenter trial testing the efficacy and safety of a novel mechlorethamine, 0.02%, gel in mycosis fungoides.
Lessin SR; Duvic M; Guitart J; Pandya AG; Strober BE; Olsen EA; Hull CM; Knobler EH; Rook AH; Kim EJ; Naylor MF; Adelson DM; Kimball AB; Wood GS; Sundram U; Wu H; Kim YH
JAMA Dermatol; 2013 Jan; 149(1):25-32. PubMed ID: 23069814
[TBL] [Abstract][Full Text] [Related]
4. Gelling Your Dermatology Nursing Practice: A Practical Guide for Managing the Treatment of Mycosis Fungoides Cutaneous T-Cell Lymphoma With Mechlorethamine Gel.
McCann SA; Chase AB; Tawa MC
J Dermatol Nurses Assoc; 2016 May; 8(3):180-192. PubMed ID: 28529678
[TBL] [Abstract][Full Text] [Related]
5. Chlormethine Gel for the Treatment of Mycosis Fungoides (Cutaneous T-cell Lymphoma) in Canada.
Gniadecki R; Paron E
Skin Therapy Lett; 2023 Mar; 28(2):1-5. PubMed ID: 37054720
[TBL] [Abstract][Full Text] [Related]
6. Management of Mycosis Fungoides with Topical Chlormethine/Mechlorethamine Gel: A Columbia University Cutaneous Lymphoma Center Experience.
Garcia-Saleem TJ; Stonesifer CJ; Khaleel AE; Geskin LJ
Acta Derm Venereol; 2021 Sep; 101(9):adv00544. PubMed ID: 34436621
[TBL] [Abstract][Full Text] [Related]
7. Clinical potential of mechlorethamine gel for the topical treatment of mycosis fungoides-type cutaneous T-cell lymphoma: a review on current efficacy and safety data.
Liner K; Brown C; McGirt LY
Drug Des Devel Ther; 2018; 12():241-254. PubMed ID: 29440874
[TBL] [Abstract][Full Text] [Related]
8. Treatment of early-stage mycosis fungoides with twice-weekly applications of mechlorethamine and topical corticosteroids: a prospective study.
de Quatrebarbes J; Estève E; Bagot M; Bernard P; Beylot-Barry M; Delaunay M; D'Incan M; Souteyrand P; Vaillant L; Cordel N; Courville P; Joly P
Arch Dermatol; 2005 Sep; 141(9):1117-20. PubMed ID: 16172308
[TBL] [Abstract][Full Text] [Related]
9. The PROVe Study: US Real-World Experience with Chlormethine/Mechlorethamine Gel in Combination with Other Therapies for Patients with Mycosis Fungoides Cutaneous T-Cell Lymphoma.
Kim EJ; Guitart J; Querfeld C; Girardi M; Musiek A; Akilov OE; Angello JT; Bailey WL; Geskin LJ
Am J Clin Dermatol; 2021 May; 22(3):407-414. PubMed ID: 33656660
[TBL] [Abstract][Full Text] [Related]
10. In brief: mechlorethamine gel (Valchlor) for cutaneous T-Cell lymphoma.
Med Lett Drugs Ther; 2015 Apr; 57(1467):e66. PubMed ID: 25988964
[No Abstract] [Full Text] [Related]
11. Maintenance and Concomitant Therapy Use with Chlormethine Gel Among Patients with Stage IA/IB Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Real-World Evidence Study.
Querfeld C; Nelson WW; Gor D; Pashos CL; Doan QV; Turini M; Angello JT; Geskin LJ
Dermatol Ther (Heidelb); 2022 Dec; 12(12):2781-2795. PubMed ID: 36284059
[TBL] [Abstract][Full Text] [Related]
12. Topical treatment of early cutaneous T-cell lymphoma.
Ramsay DL; Meller JA; Zackheim HS
Hematol Oncol Clin North Am; 1995 Oct; 9(5):1031-56. PubMed ID: 8522483
[TBL] [Abstract][Full Text] [Related]
13. Real-world experience with mechlorethamine gel in patients with mycosis fungoides-cutaneous lymphoma: Preliminary findings from a prospective observational study.
Kim EJ; Geskin L; Guitart J; Querfeld C; Girardi M; Musiek A; Mink DR; Williams MJ; Angello JT; Bailey WL
J Am Acad Dermatol; 2020 Sep; 83(3):928-930. PubMed ID: 32089294
[No Abstract] [Full Text] [Related]
14. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
15. Valchlor maintenance therapy for patients with mycosis fungoides who received low dose total skin electron beam treatment.
Jennings T; Duffy R; Gochoco A; Knoblauch K; Shi W; Alpdogan SO; Porcu P; Werner-Wasik M; Sahu J
Chin Clin Oncol; 2019 Feb; 8(1):13. PubMed ID: 30525753
[TBL] [Abstract][Full Text] [Related]
16. Response to Chlormethine/Mechlorethamine gel Maintenance Treatment Regimen in Patients With Mycosis Fungoides: A Single-center Retrospective Study.
Correia E; Krishnasamy S; Suriano JG; Shi W; Alpdogan SO; Sahu J; Porcu P; Nikbakht N
Clin Lymphoma Myeloma Leuk; 2022 Aug; 22(8):581-588. PubMed ID: 35393251
[TBL] [Abstract][Full Text] [Related]
17. Mechlorethamine Hydrochloride Gel in the Treatment of Mycosis Fungoides-Type Cutaneous T-Cell Lymphoma (MF-CTCL): A Focus on Patient Selection and Special Considerations.
Crimp C; Gangal A; Tarabadkar ES; Shinohara MM
Cancer Manag Res; 2022; 14():3271-3279. PubMed ID: 36444357
[TBL] [Abstract][Full Text] [Related]
18. Milia in regressing plaques of mycosis fungoides: provoked by topical nitrogen mustard or not?
Kalayciyan A; Oguz O; Demirkesen C; Serdaroglu S; Kotogyan A
Int J Dermatol; 2004 Dec; 43(12):953-6. PubMed ID: 15569030
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of a polymerase chain reaction-detectable dominant T-lymphocyte clone in cutaneous lesions of patients with mycosis fungoides.
Delfau-Larue MH; Dalac S; Lepage E; Petrella T; Wechsler J; Farcet JP; Bagot M
Blood; 1998 Nov; 92(9):3376-80. PubMed ID: 9787176
[TBL] [Abstract][Full Text] [Related]
20. Topical chemotherapy of mycosis fungoides.
Grekin DA; Zackheim HS; Epstein EH
Cutis; 1979 Nov; 24(5):543-6. PubMed ID: 520032
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
